Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie I Fletcher

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Molecular Cell|February 8, 2005
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic functionLin Chen, Simon N Willis, Andrew Wei, et al.
Biochemical Pharmacology|July 15, 2019
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cellsChristine C Gana, Kimberley M Hanssen, Denise M T Yu, et al.
Oncotarget|February 6, 2016
The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expressionAndrew E Tee, Bing Liu, Renhua Song, et al.
International Journal of Cancer|February 23, 2020
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastomaAndrew E Tee, Olivia C Ciampa, Matthew Wong, et al.
Cancer Research|December 29, 2011
N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastomaJamie I Fletcher, Samuele Gherardi, Jayne Murray, et al.
Journal of Adolescent and Young Adult Oncology|July 23, 2021
"We Have All This Knowledge to Give, So Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research PrioritiesClarissa E Schilstra, Ursula M Sansom-Daly, Maria Schaffer, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Cell|March 27, 2007
Programmed anuclear cell death delimits platelet life spanKylie D Mason, Marina R Carpinelli, Jamie I Fletcher, et al.
Expert Opinion on Drug Discovery|November 22, 2021
Methodological advances in the discovery of novel neuroblastoma therapeuticsMiguel F Segura, Aroa Soriano, Josep Roma, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Molecular Cell|February 8, 2005
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic functionLin Chen, Simon N Willis, Andrew Wei, et al.
Biochemical Pharmacology|July 15, 2019
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cellsChristine C Gana, Kimberley M Hanssen, Denise M T Yu, et al.
Oncotarget|February 6, 2016
The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expressionAndrew E Tee, Bing Liu, Renhua Song, et al.
International Journal of Cancer|February 23, 2020
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastomaAndrew E Tee, Olivia C Ciampa, Matthew Wong, et al.
Cancer Research|December 29, 2011
N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastomaJamie I Fletcher, Samuele Gherardi, Jayne Murray, et al.
Journal of Adolescent and Young Adult Oncology|July 23, 2021
"We Have All This Knowledge to Give, So Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research PrioritiesClarissa E Schilstra, Ursula M Sansom-Daly, Maria Schaffer, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Cell|March 27, 2007
Programmed anuclear cell death delimits platelet life spanKylie D Mason, Marina R Carpinelli, Jamie I Fletcher, et al.
Expert Opinion on Drug Discovery|November 22, 2021
Methodological advances in the discovery of novel neuroblastoma therapeuticsMiguel F Segura, Aroa Soriano, Josep Roma, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Pageof 6